SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821825-22-000009
Filing Date
2022-08-05
Accepted
2022-08-04 18:02:03
Documents
85
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ogn-20220630.htm   iXBRL 10-Q 2235171
2 EX-31.1 ogn6302022ex311.htm EX-31.1 7686
3 EX-31.2 ogn6302022ex312.htm EX-31.2 7807
4 EX-32.1 ogn6302022ex321.htm EX-32.1 3771
5 EX-32.2 ogn6302022ex322.htm EX-32.2 3479
  Complete submission text file 0001821825-22-000009.txt   10176681

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogn-20220630.xsd EX-101.SCH 62463
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ogn-20220630_cal.xml EX-101.CAL 77374
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ogn-20220630_def.xml EX-101.DEF 293279
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogn-20220630_lab.xml EX-101.LAB 705466
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogn-20220630_pre.xml EX-101.PRE 473992
79 EXTRACTED XBRL INSTANCE DOCUMENT ogn-20220630_htm.xml XML 2274665
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

IRS No.: 464838035 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40235 | Film No.: 221138024
SIC: 2834 Pharmaceutical Preparations